ConductScience.org, home

Paper29633692

Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.

Ferrari A and 3 others. Funct Neurol, 2018. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal. Papers, record 29633692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29633692

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.
PubMed
Journal
Funct Neurol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
3.03
iCite
Revised in PubMed
2019-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ferrari AA
2Manca MM
3Tugnoli VV
4Alberto LL

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Botulinum Toxins, Type AMajor topic
Neuromuscular AgentsMajor topic
Humans

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119726016Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients.Neurol Res2010https://conductscience.org/library/papers/19726016PubMed
227268041In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA.Neurosci Lett2016https://conductscience.org/library/papers/27268041PubMed
315811212Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.Curr Med Res Opin2005https://conductscience.org/library/papers/15811212PubMed
420569068Botulinum toxin type A in post-stroke upper limb spasticity.Curr Med Res Opin2010https://conductscience.org/library/papers/20569068PubMed
526866491The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems.Semin Neurol2016https://conductscience.org/library/papers/26866491PubMed
67608697Dose standardisation of botulinum toxin.J Neurol Neurosurg Psychiatry1995https://conductscience.org/library/papers/7608697PubMed
717163773The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication.ACS Chem Biol2006https://conductscience.org/library/papers/17163773PubMed
827910097Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.Headache2017https://conductscience.org/library/papers/27910097PubMed
927830925Headache, low back pain, other nociceptive and mixed pain conditions in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.Eur J Phys Rehabil Med2016https://conductscience.org/library/papers/27830925PubMed
1021277940Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments.Neuroscience2011https://conductscience.org/library/papers/21277940PubMed
1118978494Potency evaluation of a formulated drug product containing 150-kd botulinum neurotoxin type A.Clin Neuropharmacol2009https://conductscience.org/library/papers/18978494PubMed
1223185348Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay.PLoS One2012https://conductscience.org/library/papers/23185348PubMed
1328356439Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Pharmacol Rev2017https://conductscience.org/library/papers/28356439PubMed
1411909903Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.J Neurol Neurosurg Psychiatry2002https://conductscience.org/library/papers/11909903PubMed
1526976927British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.Pract Neurol2016https://conductscience.org/library/papers/26976927PubMed
168613365Molecular composition of Clostridium botulinum type A progenitor toxins.Infect Immun1996https://conductscience.org/library/papers/8613365PubMed
1721971766Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay.J Neural Transm (Vienna)2012https://conductscience.org/library/papers/21971766PubMed
189750920Dose standardization of botulinum toxin.Adv Neurol1998https://conductscience.org/library/papers/9750920PubMed
1925336912Botulinum toxin type A products are not interchangeable: a review of the evidence.Biologics2014https://conductscience.org/library/papers/25336912PubMed
2024995688A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.Res Dev Disabil2014https://conductscience.org/library/papers/24995688PubMed

See all 79 referencesDownload CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
42712115Ultrasound-guided botulinum toxin injection in patients with chronic plantar fasciitis: comparison of plantar fascia origin injection and the babcock method-a randomized controlled trial.Future Sci OA2026https://conductscience.org/library/papers/42712115PubMed
42033152Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis.J Cosmet Dermatol2026https://conductscience.org/library/papers/42033152PubMed
41745765Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins.Toxins (Basel)2026https://conductscience.org/library/papers/41745765PubMed
41180523Comparative analysis of onabotulinum toxin type-A injection techniques in older adults with blepharospasm: a retrospective cohort study.Front Neurol2025https://conductscience.org/library/papers/41180523PubMed
41150202RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity.Toxins (Basel)2025https://conductscience.org/library/papers/41150202PubMed
40762356Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review.J Neurochem2025https://conductscience.org/library/papers/40762356PubMed
40273416Exploring Nonresponse to Botulinum Toxin in Aesthetics: Narrative Review of Key Trigger Factors and Effective Management Strategies.JMIR Dermatol2025https://conductscience.org/library/papers/40273416PubMed
39998108The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review.Toxins (Basel)2025https://conductscience.org/library/papers/39998108PubMed
39803037Parkinson's Disease: Current Treatment Modalities and Emerging Therapies.Cureus2024https://conductscience.org/library/papers/39803037PubMed
39581944Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines.Dermatol Ther (Heidelb)2024https://conductscience.org/library/papers/39581944PubMed
39560920Muscle type-specific effects of bilateral abobotulinumtoxinA injection on muscle growth and contractile function in spastic mice.FASEB J2024https://conductscience.org/library/papers/39560920PubMed
39057946Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature.Toxins (Basel)2024https://conductscience.org/library/papers/39057946PubMed
38922160Update on Non-Interchangeability of Botulinum Neurotoxin Products.Toxins (Basel)2024https://conductscience.org/library/papers/38922160PubMed
38859620Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia.Eur J Neurol2024https://conductscience.org/library/papers/38859620PubMed
38628704Association analyses between the variants of SNAP25, SV2C and ST3GAL2 and the efficacy of botulinum toxin A in the treatment of the primary Meige syndrome.Heliyon2024https://conductscience.org/library/papers/38628704PubMed
37893140Botulinum Toxin Injection into the Digastric Muscle: Current Clinical Use and a Report of Five Cases.Biomedicines2023https://conductscience.org/library/papers/37893140PubMed
37235349Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations.Toxins (Basel)2023https://conductscience.org/library/papers/37235349PubMed
36923693A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA.Clin Cosmet Investig Dermatol2023https://conductscience.org/library/papers/36923693PubMed
36675200Distribution of Cleaved SNAP-25 in the Rat Brain, following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum.Int J Mol Sci2023https://conductscience.org/library/papers/36675200PubMed
35965898Incobotulinum Toxin A with a One-year Long-lasting Effect for Trapezius Contouring and Superior Efficacy for the Treatment of Trapezius Myalgia.J Cutan Aesthet Surg2022https://conductscience.org/library/papers/35965898PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29633692

GET https://conductscience.org/api/papers/v1/29633692/references?page=2